登录

Yuwell Announces Acquirement of 66 Vision at¥37.42M , to Enrich the Pipeline of Ophthalmic Products

作者: Mailman 2019-11-11 16:48
六六视觉
http://www.66vision.com/
企业数据由 动脉橙 提供支持
眼科医疗器械厂商 | 未公开 | 被并购
中国-江苏
2019-10-30
融资金额:RMB¥3742.23万
鱼跃医疗
查看

According to Yiou.com, on October 31, Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. ("Yuwell") announced that it intends to purchase 95.95% shares of Suzhou 66 VISION TECH Co., LTD. ("66 Vision”) with 37.42 million yuan, which made the target company become a subsidiary of Yuwell.


The acquisition of 66 Vision is mainly aimed at enriching its product categories in the field of ophthalmic devices. 


66 Vision, reformed from Suzhou Medical Instrument General Factory which is established in 1956, is mainly engaged in R&D, manufacturing, sales, and service of ophthalmic devices. The products include slit lamp microscopes, operation microscope, IOL, surgical instrument, electronic device and laser medical device with more than 160 varieties and 600 specifications. 


66 Vision has the R&D capability in optics, machinery, electronics, fine processing and other high technology, such as microelectronics, polymer, lasers, and ultrasound and has also fully implemented the digital design, manufacturing, and management to be the largest R&D and manufacturing base of ophthalmic medical devices in China. 66 Ophthalmic Instrument was awarded as Jiangsu's famous brand product and 66 Ophthalmic Microscopes have been awarded the China Top Brand.


Yuwell was established in Danyang, Jiangsu Province in 1998. In April 2008, the company listed on Shenzhen Stock Exchange. Then it increased input in technological innovation and development of products with the support of the capital market. What’s more, Yuwell grew with amazing speed by merger and acquisition. 


Yuyue medical has over 500 product categories and nearly 10,000 kinds of products, covering family medical instruments, hospital equipment, clinical consumables, first-aid equipment, traditional Chinese medicine instruments, surgical instruments, medicinal plaster and polymer dressing, hospital disinfection and infection control. 

注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

【首发】天宸生物完成近亿元A+轮融资,加速打造创新国产眼科器械

超90亿元投资涌入数字疗法,明星资本都在怎么投?

【首发】朗目医疗完成数千万元Pre-A轮融资,以原创技术引领眼科产业发展

【首发】微清医疗完成数千万元C轮融资,加速提升中国高端眼科影像设备全球市占率

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

Haohai Biological Lists on Shanghai's Star Market

2019-11-11
下一篇

Inkbit完成1200万美元的股权融资,将利用机器视觉及机器学习扩展3D打印可用材料

2019-11-11